Company Update

DIPNA PHARMACHEM LIMITED has announced that its board approved the audited financial results for the quarter and year ended March 31, 2026. The company reported a net profit of Rs. 2.63 Cr for the year and Rs. 0.18 Cr for the quarter.

Revenue from operations for the year stood at Rs. 129.08 Cr, with Rs. 2.02 Cr in the quarter.

The board also approved the statement for deviations in preferential issue funds.

The company confirmed no deviations in the utilization of approximately Rs. 21.13 Cr raised through convertible warrants, with funds deployed towards working capital and general corporate purposes.